report

Global Neurovascular Thrombectomy Devices Market Size, Trends & Analysis - Forecasts to 2026 By Type (Stents Retriever, Aspiration Catheter), By End User (Hospitals, Neuro-Catheterization Laboratories, Specialized Neurosurgery Centers), By Region (North America, Europe, Asia Pacific and Rest of the World); Vendor Landscape, End User Landscape and Company Market Share & Competitor Analysis

  • Published Date: January 28 : 2020
  • Base Year for Estimate: 2019
  • Report Id:1646

Neurovascular Thrombectomy Devices Market Insights

The global neurovascular thrombectomy devices market is estimated to witness a high CAGR during the forecast period (2019-2026). Increased disease management options for strokes is expected to propel the market growth during the forecast period. Neurovascular thrombectomy devices are used for the removal of a blood clot in the neurovascular vessels during an acute ischemic stroke.

Growing population along with rising health issues across the globe are some of the major factors driving the market growth. Favorable reimbursement policies and government subsidies in developing nations also expands the market growth. Increasing mortality rate due to ischemic stroke has increased the need for neurovascular thrombectomy devices for disease management.

Neurovascular Thrombectomy Devices Market: By Type

On the basis of type, the global neurovascular thrombectomy devices market is segmented into stents retriever and aspiration catheter. The stents retriever segment is expected to hold the largest market share during the forecast period. Stent retriever is a self-expanding stent used to retrieve the thromboembolus and restore blood flow and they are deployed by a catheter that is threaded through the clot. Aspiration catheter segment is expected to grow at a significant CAGR during the forecast period. Aspiration catheter is a micro-vacuum that is fed into affected vessels to remove large vessel occlusions during an acute ischemic stroke.

Neurovascular Thrombectomy Devices Market: By End User

On the basis of end user, the market is segmented into hospitals, neuro-catheterization laboratories, and specialized neurosurgery centers. The hospitals segment is expected to hold a significant market share during the forecast period. Surgical thrombectomy is a surgery performed for the removal of a blood clot from an artery or vein. The surgery is performed when the blood coagulates and clusters to form a blood clot in the blood vessels. In operation, an incision is made using thrombectomy devices in a blood vessel. Growing healthcare expenditure along with increased researches and studies in the field of thrombectomy are driving the market growth. Neuro-catheterization laboratories segment is also expected to grow during the forecast period.

Neurovascular Thrombectomy Devices Market: By Region

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Middle East Africa and Central & South America. North America region is expected to dominate the global neurovascular thrombectomy devices market during the forecast period. Increased mortality rate in the USA along with increased need for thrombectomy devices for better disease management is driving the market growth. According to the data published by American stroke association, nearly 8 lakh cases of strokes are diagnosed in the United States and nearly 130 thousand deaths are reported every year.  Asia Pacific region is expected to grow at the significant CAGR during the forecast period. Increasing healthcare expenditure along with favorable government policies is driving the market growth in the region.

Neurovascular Thrombectomy Devices Market: End Use Landscape

The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the markets are UCLA Medical Center, and Massachusetts General Hospital among others.

Neurovascular Thrombectomy Devices Market: Vendor Landscape

The report contains a chapter dedicated to vendors operating in the Neurovascular Thrombectomy Devices market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.

Neurovascular Thrombectomy Devices Market Share & Competitor Analysis

Some of the key players operating in the Neurovascular Thrombectomy Devices market are Johnson Services, Inc., Medtronic, Penumbra Inc., Stryker, Argon Medical, Teleflex Incorporated, Boston Scientific Corporation, Edwards Lifesciences Corporation, Acandis Gmbh, and Argon Medical Inc among others.

In November 2019, Johnson Services launched revascularization device which is manufactured with an innovative, dual layer design to engage and grip clots differently.

In April 2019, Medtronic launched new product Solitaire X revascularization device for treating acute ischemic stroke in the U.S.

Request A Free Sample Report
Request For Customization

 

What questions do you have? Get quick response from our industry experts. Request a Free Consultation